Financial statements Microbiotix
Balance sheet data of MICROBIOTIX
|
Year
|
2018
|
2019
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|
| Total assets | 310 884,34 | 500 665,45 | 491 516,58 | 603 519,44 | 841 786,21 |
| A. Fixed assets | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| B. Current assets | 310 884,34 | 500 665,45 | 491 516,58 | 603 519,44 | 841 786,21 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | - | - | - |
| D. Own shares (stocks) | 0,00 | 0,00 | - | - | - |
| Total liabilities | 310 884,34 | 500 665,45 | 491 516,58 | 603 519,44 | 841 786,21 |
| A. Equity | 291 174,25 | 320 787,51 | 331 843,20 | 560 779,19 | 829 981,55 |
| B. Liabilities and provisions for liabilities | 19 710,09 | 179 877,94 | 159 673,38 | 42 740,25 | 11 804,66 |
| I. Long-term liabilities | 0,00 | 0,00 | 2 250,00 | 0,00 | 0,00 |
| II. Short-term liabilities | 19 710,09 | 179 877,94 | 157 423,38 | 42 740,25 | 11 804,66 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.